Li, Yue http://orcid.org/0000-0001-8198-9911
Stockton, Michael E.
Eisinger, Brian E.
Zhao, Yinghua http://orcid.org/0000-0003-2007-1167
Miller, Jessica L. http://orcid.org/0000-0002-3093-2234
Bhuiyan, Ismat
Gao, Yu
Wu, Zhiping
Peng, Junmin http://orcid.org/0000-0003-0472-7648
Zhao, Xinyu http://orcid.org/0000-0002-5128-4424
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (F32NS094120, R21NS095632, R21NS098767)
UW Hilldale Undergraduate Research Fellowship
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM114260)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH078972, R01MH080434, R56MH113146)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090256)
UW-Madison, Wisconsin Alumni Research Foundation, Jenni and Kyle Professorship, UW Vilas Trust
Article History
Received: 14 October 2017
Accepted: 23 May 2018
First Online: 27 June 2018
Competing interests
: X.Z. and Y.L. are inventors of a patent (“METHODS FOR TREATING COGNITIVE DEFICITS ASSOCIATED WITH FRAGILE X SYNDROME” United States US 9,962,380 B2). The remaining authors declare no competing interests.